International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers
- 22 July 2010
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 32 (2) , 315-319
- https://doi.org/10.1002/jmri.22245
Abstract
To examine the reproducibility of the single breathhold T2* technique from different scanners, after installation of standard methodology in five international centers. Up to 10 patients from each center were scanned twice locally for local interstudy reproducibility of heart and liver T2*, and then flown to a central MR facility to be rescanned on a reference scanner for intercenter reproducibility. Interobserver reproducibility for all scans was also assessed. Of the 49 patients scanned, the intercenter reproducibility for T2* was 5.9% for the heart and 5.8% for the liver. Local interstudy reproducibility for T2* was 7.4% for the heart and 4.6% for the liver. Interobserver reproducibility for T2* was 5.4% for the heart and 4.4% for the liver. These data indicate that T2* MR may be developed into a widespread test for tissue siderosis providing that well-defined and approved imaging and analysis techniques are used.Keywords
This publication has 19 references indexed in Scilit:
- MRI evaluation of tissue iron burden in patients with β-thalassaemia majorPediatric Radiology, 2007
- Magnetic resonance imaging measurement of iron overloadCurrent Opinion in Hematology, 2007
- A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic ResonanceCirculation, 2007
- Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron.2006
- Myocardial Iron Loading in Patients with Thalassemia Major on Deferoxamine ChelationJournal of Cardiovascular Magnetic Resonance, 2006
- Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosisBlood, 2006
- Intercentre Reproducibility of Magnetic Resonance T2* Measurements of Myocardial Iron in ThalassaemiaThe International Journal of Cardiovascular Imaging, 2005
- Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron CardiomyopathyCirculation, 2005
- Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonanceBritish Journal of Haematology, 2004
- Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.2004